Long School of Medicine

KSAT 12: When will we see a COVID-19 vaccine? UT Health infectious disease expert weighs in

October 20, 2020
 

Dr. Jason Bowling, Infectious Diseases, weighs in on when we might see a COVID-19 vaccine for KSAT-12 by breaking down the steps in vaccine development. Read and watch the interview.


Drug Target Review: SARS-CoV-2 papain-like protease could be a novel drug target

October 20, 2020
 

Researchers from UT Health San Antonio, US, and the Wroclaw University of Science and Technology, Poland, found that SARS-CoV-2-PLpro promotes infection by sensing and processing both viral and human proteins. Read the story.


KSAT 12: WHO study finds remdesivir didn’t help COVID-19 patients; UT Health weighs in

October 19, 2020
 

KSAT 12 localized the national story involving a statement of the World Health Organization (WHO) with an interview of Dr. Thomas Patterson, Infectious Diseases, who is leading a UT Health San Antonio-University Health System study site on remdesivir, as part of the Adaptive COVID-19 Treatment Trials (ACTT) sponsored by the National Institute of Allergy and […]


Medical News Today: US election 2020: Undocumented status and mental healthcare access

October 19, 2020
 

In this perspective article, Luz Maria Garcini, PhD, MPH, assistant professor at the Center for Research to Advance Community Health at UT Health San Antonio, considers what the upcoming presidential election might mean for the access to mental health care of people living with undocumented status in the United States. Read the article.


KSAT 12: ‘Don’t forget to wash your hands’ says San Antonio infectious disease doctor in KSAT Q&A

October 19, 2020
 

Dr. Ruth Berggren, Infectious Diseases, continues her weekly appearance on KSAT 12 with advice about washing hands to avoid not only COVID-19 but also the common cold. Watch the interview.


Magnesium energetics

Researchers solve 100-year-old mystery of what activates magnesium ions in the cell

October 15, 2020
 

The discovery is expected to be a springboard for future development of novel drugs to treat cardiovascular disease, metabolic disorders such as diabetes and other diseases.